Ausgabe 4/2021
Inhalt (14 Artikel)
Sexual Dimorphisms in Nonalcoholic Fatty Liver Disease
Jessica Musto, Erin K. Spengler, Margarita N. German
Recurrent NASH Post-liver Transplant: Implications and Treatment
Niranjani Venkateswaran, Scott Weismiller, Karen Krok
Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
Chung-Heng Liu, Gregory Habig, Christa Smaltz, Dina Halegoua-DeMarzio
Screening for Non-alcoholic Fatty Liver Disease in Current Practice
Margaret Spinosa, She-Yan Wong
Reframing: Sociopolitical Conditions and Geographical Risk Factors for Hepatitis B Screening and Elimination
Nasreen Syeda Quadri, Angela Yu Zhang, Chiazotam Ekekezie
Viral Hepatitis B—Management in Children
Christine K. Lee, Maureen M. Jonas
Real-World Safety and Effectiveness of Oral Nucleos(t)ide Analogs in the Treatment of Chronic Hepatitis B Virus Infection
Robert J. Wong, Ramsey C. Cheung
Management of Hepatitis B in Persons Who Inject Drugs (PWID)
Shang-Chin Huang, Jia-Horng Kao
Diagnostic Testing for SARS-CoV-2 Infection
Emmanuel Thomas, Stephanie Delabat, David M. Andrews
Addressing Hepatitis B in the Context of Hepatitis C
Lauren Myers, Arnab Mitra, Joseph Ahn
Care After Cure: Long-term Follow-up in Hepatitis C
Kostantinos Evangelos Morris, Andrew Joseph Muir
HCV and Liver Transplantation
Alyson Kaplan, Robert S. Brown Jr
Burden, Quality of Life, and Palliative Care for Family Caregivers of Individuals with Advanced Liver Disease: a Systematic Literature Review
Christopher D. Woodrell, Arnab Mitra, Andrew Hamilton, Lissi Hansen